<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2436">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03075176</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 95434</org_study_id>
    <nct_id>NCT03075176</nct_id>
  </id_info>
  <brief_title>Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy</brief_title>
  <official_title>Outcomes of Topography-guided LASIK and Photorefractive Keratectomy Compared to Wavefront Optimized LASIK and Photorefractive Keratectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the difference in results between eyes that have been treated wavefront
      optimized laser vision correction compared to eyes treated with topography-guided laser
      vision correction. Each participant will receive wavefront optimized correction in one eye
      and topography-guided correction in the other.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each participant will receive wavefront optimized surgery in one eye and topography-guided surgery in the second eye.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant</masking>
    <masking_description>Participants will be masked as to which type of surgery they receive in either eye.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 1 day post surgery</measure>
    <time_frame>1 day</time_frame>
    <description>uncorrected visual acuity will be measured at baseline and day 1 (+/- 1 day)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 1 week post surgery</measure>
    <time_frame>1 week</time_frame>
    <description>uncorrected visual acuity will be measured at week 1 (+/- 3 days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 1 month post surgery</measure>
    <time_frame>1 month</time_frame>
    <description>uncorrected visual acuity will be measured at month 1 (+/- 10 days)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 3 months post surgery</measure>
    <time_frame>3 months</time_frame>
    <description>uncorrected visual acuity will be measured at month 1 (+/- 2 weeks)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 6 months post surgery</measure>
    <time_frame>6 months</time_frame>
    <description>uncorrected visual acuity will be measured at month 6 (+/- 1 month)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in uncorrected visual acuity at 12 months post surgery</measure>
    <time_frame>12 months</time_frame>
    <description>uncorrected visual acuity will be measured at month 12 (+/- 1 month)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in contrast sensitivity at 3 months post surgery</measure>
    <time_frame>3 months</time_frame>
    <description>Contrast sensitivity will be tested pre-operatively and 3 months post-operatively (+/- 14 days)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in degree of higher order aberrations at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>Aberrometry measurements will be taken pre-operatively and 3 months post surgery (+/- 14 days)</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in quality of life score at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>The validated QIRC survery will be administered pre-operatively and 3 months post surgery (+/- 14 days)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Surgery</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Wavefront optimized LASIK or PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Topography-guided LASIK or PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wavefront optimized LASIK or PRK</intervention_name>
    <description>Wavefront optimized laser vision correction</description>
    <arm_group_label>Wavefront optimized LASIK or PRK</arm_group_label>
    <arm_group_label>Topography-guided LASIK or PRK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Topography-guided LASIK or PRK</intervention_name>
    <description>Topography-guided laser vision correction</description>
    <arm_group_label>Wavefront optimized LASIK or PRK</arm_group_label>
    <arm_group_label>Topography-guided LASIK or PRK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All subjects who are deemed suitable candidates for laser refractive surgery after
             routine refractive surgery screening will be considered eligible for participation in
             this study.

        Subjects must be at least 21 years of age and not pregnant or nursing (due to fluctuations
        in visual parameters during pregnancy)

        Exclusion Criteria:

          -  Any patient who is not a suitable candidate for LASIK or PRK will not be included.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Mifflin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah Moran Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Mifflin, MD</last_name>
    <phone>801-585-7689</phone>
    <email>Mark.Mifflin@hsc.utah.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moran Eye Center - Midvalley Location</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Mifflin, MD</last_name>
      <phone>801-583-3447</phone>
      <email>Mark.Mifflin@hsc.utah.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 4, 2017</lastchanged_date>
  <firstreceived_date>February 18, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Mark Mifflin</investigator_full_name>
    <investigator_title>Professor, Ophthalmology/Visual Sciences</investigator_title>
  </responsible_party>
  <keyword>Photorefractive keratectomy</keyword>
  <keyword>Laser-assisted in situ keratomileusis</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
